Position in EXEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$416,253,693
+$81,899,982 QoQ
Shares Held
7,650,316
-1.9% QoQ
Ownership
3.09%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#10
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. EXEL ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $416,253,693 | 7,650,316 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $334,353,711 | 7,795,610 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $330,003,214 | 7,529,163 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $316,810,606 | 7,670,959 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $328,196,273 | 7,445,469 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $273,842,285 | 7,417,180 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $171,755,039 | 5,157,809 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $133,977,877 | 5,162,924 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $116,084,603 | 5,166,204 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $124,387,083 | 5,241,765 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $123,436,178 | 5,145,318 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $110,883,178 | 5,074,745 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $96,190,242 | 5,033,503 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $92,548,801 | 4,768,099 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $73,243,275 | 4,566,289 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $68,009,585 | 4,337,346 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $88,747,082 | 4,262,588 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $96,884,665 | 4,273,695 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $75,255,725 | 4,116,834 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $84,712,736 | 4,007,225 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $72,392,432 | 3,973,240 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $88,600,871 | 3,922,128 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $76,686,425 | 3,820,948 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $87,643,567 | 3,584,604 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $87,931,321 | 3,703,931 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $62,320,797 | 3,619,094 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||